New HPV vaccine shows strong immune response in chinese women and girls
NCT ID NCT03903562
First seen Apr 13, 2026 · Last updated May 07, 2026 · Updated 6 times
Summary
This study tested a 9-valent HPV vaccine in 1990 healthy Chinese females aged 9 to 45. The goal was to see if the vaccine triggers a strong immune response and is safe. Results showed the vaccine works well across all age groups, helping protect against HPV infections that can cause cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLOMAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaihua country Center for Disease Control and Prevention ( Site 0002)
Quzhou, Zhejiang, 324300, China
-
Shaoxing keqiao center for disease prevention and control ( Site 0001)
Shaoxing, Zhejiang, 312030, China
Conditions
Explore the condition pages connected to this study.